| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Lalwani Nikhil is a President &CEO at ANI PHARMACEUTICALS INC. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $33.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sell | 56,960 | $85.93 | $4,894,572.80 | -12.2% | +0.7% | - | |
| Nov 26, 2024 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sale+OE | 33,481 | $57.99 | $1,941,442.30 | -4.3% | -4.0% | +45.8% | |
| May 14, 2024 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sell | 16,669 | $66.10 | $1,101,820.90 | -4.2% | -9.6% | -8.6% | |
| Mar 8, 2024 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sell | 45,257 | $66.10 | $2,991,468.76 | -5.0% | +2.1% | -10.1% | |
| Aug 15, 2023 | ANIP Ani Pharmaceuticals Inc | President &CEO | Sale+OE | 68,282 | $58.32 | $3,982,547.58 | -8.8% | -16.5% | -4.3% | |
| Mar 21, 2022 | ANIP Ani Pharmaceuticals Inc | President &CEO | Buy | 7,224 | $27.69 | $199,997.16 | +4.4% | -7.0% | +48.0% |